Case Study

Acute Pain Study

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

CNS

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

Case Study

Acute Pain Study

CNS

603

Enrolled Participants

99%

Retention

90%

Medication Adherence

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

Case Study

Acute Pain Study

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

CNS

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

Case Study

Acute Pain Study

CNS

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

Case Study

Acute Pain Study

CNS

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

Case Study

Acute Pain Study

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

CNS

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

Case Study

Acute Pain Study

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

CNS

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.